1.
Prim Care Companion CNS Disord
; 22(6)2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1000400
Asunto(s)
Antidepresivos/efectos adversos , Arritmias Cardíacas/inducido químicamente , Tratamiento Farmacológico de COVID-19 , Trastorno Depresivo/tratamiento farmacológico , Cardiopatías/fisiopatología , Antivirales/efectos adversos , Arritmias Cardíacas/etiología , Fibrilación Atrial/fisiopatología , Bloqueo Atrioventricular/inducido químicamente , Bloqueo de Rama/inducido químicamente , COVID-19/fisiopatología , Cloroquina/efectos adversos , Trastorno Depresivo/fisiopatología , Humanos , Hidroxicloroquina/efectos adversos , Síndrome de QT Prolongado/inducido químicamente , Torsades de Pointes/inducido químicamente
2.
Am J Trop Med Hyg
; 103(1): 79-82, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: covidwho-822291
RESUMEN
Novel coronavirus disease (COVID-19) is a highly contagious disease caused by severe acute respiratory distress syndrome coronavirus-2 that has resulted in the current global pandemic. Currently, there is no available treatment proven to be effective against COVID-19, but multiple medications, including hydroxychloroquine (HCQ), are used off label. We report the case of a 60-year-old woman without any cardiac history who developed right bundle brunch block and critically prolonged corrected electrocardiographic QT interval (QTc 631 ms) after treatment for 3 days with HCQ, which resolved on discontinuation of the medication. This case highlights a significant and potentially life-threatening complication of HCQ use.